2013
DOI: 10.11648/j.ijnfs.20130203.11
|View full text |Cite
|
Sign up to set email alerts
|

Functionally Defective High Density Lipoprotein is Pro-Oxidant: a Deviation from Normal Atheroprotective Character

Abstract: High-density lipoprotein is a potential life saving antiatherogenic molecule. However, not all HDL is functionally similar, it can become dysfunctional and may increase atherosclerotic risk. At present, it is unknown, which structural alterations of HDL are essential accounting for its defective functionality and the precise pro-atherogenic mechanisms of action. This study is aimed at identification of the possible prevalence of dysfunctional HDL in subjects and its compositional and functional characterizatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 50 publications
0
8
0
Order By: Relevance
“…The effect of dysfunctional HDL on macrophage cholesterol accumulation was examined at different time intervals (6,12, and 24 h).…”
Section: Dysfunctional Hdl Promotes Lipid Accumulation In Human Mo-mmentioning
confidence: 99%
See 3 more Smart Citations
“…The effect of dysfunctional HDL on macrophage cholesterol accumulation was examined at different time intervals (6,12, and 24 h).…”
Section: Dysfunctional Hdl Promotes Lipid Accumulation In Human Mo-mmentioning
confidence: 99%
“…Excess cholesterol is toxic to the cells. To examine the effect of piHDL on cytotoxicity, human macrophages were exposed to piHDL at different time intervals (6,12,16, and 24 h).The cell viability rate was quantitated by MTT assay. As shown in Figure 2a, the viability of macrophages decreased gradually in a time-dependent manner in response to piHDL.…”
Section: Cytotoxic Effect Of Dysfunctional Hdlmentioning
confidence: 99%
See 2 more Smart Citations
“…Moreover, clinical trials aimed at raising the circulating HDL-cholesterol have failed to reduce the cardiovascular outcomes [30]. The doubts concerning the protective role of HDL-C have been supported by in vitro studies which indicate that the HDL-C from patients with CVD does not have a protective action, but does stimulate inflammation and free radical synthesis [60,77]. This data suggests that HDL-C, commonly recognised as protective against atherosclerosis, in some circumstances becomes pro-atherogenic and dysfunctional [79].…”
Section: Dysfunctional Hdl-cholesterolmentioning
confidence: 99%